Body mass index and risk of non-Hodgkin’s and Hodgkin’s lymphoma: A meta-analysis of prospective studies
A partir d’une revue de la littérature, cette méta-analyse d’études prospectives évalue l’association entre l’indice de masse corporelle et le risque de lymphomes
We conducted a meta-analysis of prospective studies to summarise the epidemiologic evidence regarding the association of body mass index (BMI) with non-Hodgkin’s lymphoma (NHL) and Hodgkin’s lymphoma (HL) incidence and NHL mortality. Pertinent studies were identified by searching PubMed (1966–May 2011) and the reference lists of retrieved articles. For each study, we estimated a relative risk (RR) for a 5kg/m2 increase in BMI. A random-effects model was used to combine the RR estimates from individual studies. The summary RRs for a 5kg/m2 increase in BMI were 1.07 (95% confidence intervals (CI), 1.04–1.10) for NHL incidence (16 studies, n=17,291 cases) and 1.14 (95% CI, 1.04–1.26) for NHL mortality (five studies, n=3407 cases). BMI was significantly positively associated with risk of diffuse large B-cell lymphoma (RR, 1.13; 95% CI, 1.02–1.26), but not other NHL subtypes. The difference in risk estimates for subtypes was not statistically significant (P=0.10). There was evidence of a nonlinear association between BMI and HL (P for nonlinearity=0.01) (five studies, n=1557 cases). The summary RRs of HL were 0.97 (95% CI, 0.85–1.12) for overweight and 1.41 (95% CI, 1.14–1.75) for obesity. These results indicate that BMI is positively associated with risk of NHL and HL as well as with NHL mortality.
http://linkinghub.elsevier.com/retrieve/pii/S0959804911004333?showall=true 2011